Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Mesenchymal stem cells
Non-randomized controlled open trial 		Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
BNT162b2
Non-randomized controlled open trial 		Approved by FDA Experimental Vaccine Jun/22/2022
mRNA-1273
Non-randomized controlled open trial 		Emergency use authorization Experimental Vaccine Jun/22/2022
Convalescent plasma
Non-randomized controlled open trial 		Emergency use authorization Experimental Antiviral May/16/2022
Anakinra 
Non-randomized controlled open trial 		Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Ivermectin
Non-randomized controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Baricitinib
Non-randomized controlled open trial 		Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Tocilizumab
Non-randomized controlled open trial 		Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
Non-randomized controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Ruxolitinib
Non-randomized controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021
SinaCurcumin®
Non-randomized controlled open trial 		Potential treatment - clinical evidence Experimental Antiviral Mar/28/2021
Ribavirin
Non-randomized controlled open trial 		Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021
Nitazoxanide
Non-randomized controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/16/2021
Zinc sulfate
Non-randomized controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/16/2021
Curcumin
Non-randomized controlled open trial 		Potential treatment - theoretical effect Natural product Antiviral Feb/03/2021
Daclatasvir
Non-randomized controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020
Sofosbuvir
Non-randomized controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020
Artemisinin
Non-randomized controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/02/2020
Piperaquine
Non-randomized controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/02/2020
Xuanfei Baidu decoction
Non-randomized controlled open trial 		Potential treatment - clinical evidence Experimental Unknown Oct/21/2020
Export (.csv)